Clinquest Group, B.V. based in Amsterdam, The Netherlands, is the parent corporation of a family of companies in the US and Europe that specialize in consulting services for drug discovery and development, implementation, post-approval expertise and compound partnering programs, serving the pharmaceutical, biotechnology, biomedical device and medical data industries.
Clinquest consists of Clinquest Inc., (US subsidiary), Clinquest Services B.V. (European subsidiary) and Clinquest PI (Pharmaceutical Innovations) B.V. (European drug development subsidiary).
The Company was incorporated in 1998 by Dr. Cornelis H. Wortel, M.D., Ph.D., a well-respected academic and business executive with nearly 20 years of experience in the development of biopharmaceuticals and innovative medical technologies. Dr. Wortel also has extensive experience in international academics and industrial pharmaceutical research.
Individually, our member companies provide targeted services to local clients within the biopharmaceutical industry. Working in concert, Clinquest provides a wide array of global services to our clients and partners that maximize returns on R&D investments and accelerate the delivery of safe and effective therapeutics to patients. Our clientele ranges from start-up biotech companies to fully integrated pharmaceutical organizations.